Filter Results
:
(1,120)
Show Results For
-
All HBS Web
(1,120)
- People (1)
- News (307)
- Research (683)
- Events (5)
- Multimedia (15)
- Faculty Publications (399)
Show Results For
-
All HBS Web
(1,120)
- People (1)
- News (307)
- Research (683)
- Events (5)
- Multimedia (15)
- Faculty Publications (399)
- 01 Mar 2016
- News
Alumni and Faculty Books for March 2016
Dressler (AMP 67, 1973) (Dudley Court Press) Dressler has written a love story and a travel book, filled with stories and photos of wild animals, diplomatic soirées, cultural...
View Details
- December 2004 (Revised August 2007)
- Background Note
LTCM's Profit Motive
By: Henry B. Reiling and Kevin Wall
This case summarizes the finding and reasoning inherent in the economic substance and penalty imposition holdings of the district court decision in Long Term Capital Holdings v. United States. The court upheld the IRS's contention that a transaction between Long Term...
View Details
Reiling, Henry B., and Kevin Wall. "LTCM's Profit Motive." Harvard Business School Background Note 205-054, December 2004. (Revised August 2007.)
- 26 Jun 2014
- News
Investors Always Come Back … Even to Argentina
- Article
Czech Mate: Expropriation and Investor Protection in a Converging World
By: Mihir A. Desai and Alberto Moel
This paper examines the expropriation of a foreign investor by a local partner and the subsequent resolution of that case through international arbitration in favor of the investor. Despite the investor's 99% interest in joint venture, the local partner managed to...
View Details
Keywords:
Joint Ventures;
Capital Markets;
Foreign Direct Investment;
Geographic Location;
Multinational Firms and Management;
Governance Controls;
Courts and Trials;
Rights;
Czech Republic;
United States
Desai, Mihir A., and Alberto Moel. "Czech Mate: Expropriation and Investor Protection in a Converging World." Review of Finance 12, no. 1 (2008): 221–251. (This paper is a revised version of ECGI Working Paper No. 62/2004.)
- September 2017
- Case
Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry
By: Steven Rogers and Alyssa Haywoode
Dr. William Carson, an African-American alum of Harvard University became the President and CEO of a multi billion dollar division of Otsuka, a Japan based pharmaceutical company. His ascension to this leadership position followed a thriving career in academic medicine...
View Details
Keywords:
Dr. Williams Carson;
Otsuka America Pharmaceutical;
Harvard;
Abilify;
Aripiprazole;
Health Testing and Trials;
Globalized Firms and Management;
Globalized Markets and Industries;
Cross-Cultural and Cross-Border Issues;
Decision Choices and Conditions;
Pharmaceutical Industry;
Japan
Rogers, Steven, and Alyssa Haywoode. "Dr. William Carson— Intrapreneurial Innovation in the Pharmaceutical Industry." Harvard Business School Case 318-005, September 2017.
- 11 Mar 2008
- Working Paper Summaries
Finding Missing Markets (and a disturbing epilogue): Evidence from an Export Crop Adoption and Marketing Intervention in Kenya
- 15 Oct 2001
- Research & Ideas
Four Questions for David Garvin and Michael Roberto
effective approach to decision making. It does, after all, work exceedingly well in our court system, where both sides are represented by skilled attorneys, discovery proceedings unearth common information View Details
Keywords:
by Martha Lagace
- March 2012 (Revised October 2013)
- Supplement
Gene Patents (B)
By: Richard Hamermesh and Phillip Andrews
The case updates events since the Court's ruling against Myriad Genetics on March 29, 2010 and should be used in conjunction with Gene Patents (A). On July 29, 2011, a US Appeals Court reversed the prior ruling against Myriad. On September 16, 2011, the first major...
View Details
Keywords:
Courts and Trials;
Patents;
Genetics;
Judgments;
Investment;
Biotechnology Industry;
United States
Hamermesh, Richard, and Phillip Andrews. "Gene Patents (B)." Harvard Business School Supplement 812-130, March 2012. (Revised October 2013.)
- Web
Teaching Cases - Institute For Strategy And Competitiveness
2008, patients seeking a hip or knee replacement in Stockholm County faced wait times of up to two years of sometimes debilitating pain, intermittent missed work and income, and the View Details
- August 2013
- Course Overview Note
Building Life Science Businesses Fall 2013: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2013 class Building Life Science Businesses.
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe
Hamermesh, Richard G. "Building Life Science Businesses Fall 2013: Course Outline and Syllabus." Harvard Business School Course Overview Note 814-019, August 2013.
- February 2020
- Teaching Note
Theranos: Who Has Blood on Their Hands? (A) and (B)
By: Nien-he Hsieh and Christina R. Wing
Teaching Note for HBS Nos. 619-039 and 320-091.
View Details
- Web
Buy Now, Pay Later: Credit and Information Technology
the Courts Credit and Information Technology Credit in a Consumer Society Research Links Credits “The ratings given by the large commercial ratingsagencies are on the whole remarkably exact.” — Peter P....
View Details
- 03 Jun 2020
- Research & Ideas
Who Guarantees Your Workplace Is Safe for Return?
As we start to think about returning to work, shopping, and recreation, there is much talk about transformed workplaces and innovative social distancing designs. But how will companies, workers, View Details
- September 2012 (Revised September 2012)
- Course Overview Note
Building Life Science Businesses Fall 2012: Course Outline and Syllabus
This Course Outline and Syllabus gives an overview of the Fall 2012 class Building Life Science Businesses
View Details
Keywords:
Healthcare Ventures;
Entrepreneurial Management;
Entrepreneurship;
Entrepreneurs;
Health Care and Treatment;
Health Testing and Trials;
Medical Specialties;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Medical Devices and Supplies Industry;
Asia;
North America;
Europe
- 11 Aug 2003
- Research & Ideas
Cheap, Fast, and In Control: How Tech Aids Innovation
Harvard Business School, discusses how businesses can sidestep the often prohibitive costs and time-consuming trials of experimentation by implementing new technologies. Wendy Guild: We've all heard the old...
View Details
Keywords:
by Wendy Guild
- 01 Aug 2017
- First Look
First Look at New Research and Ideas, August 1
Abstract—Objective: Assess whether a commitment contract informed by behavioral economics leads to persistent virologic suppression among HIV-positive patients with poor antiretroviral therapy (ART) adherence. Design: Single-center pilot randomized clinical View Details
Keywords:
Sean Silverthorne
- 15 Dec 2008
- Research & Ideas
The Surprisingly Successful Marriages of Multinationals and Social Brands
appreciate the social value dimension of the mice's missions or failing to respect their distinctive operating culture can create incompatibility and conflict that will probably cancel the courting or sour...
View Details
- June 2002
- Background Note
Note on the Value of Life
By: Michael A. Wheeler and Carlos Gonzalez
This case summarizes how American courts measure damages in wrongful death suits. Various standards are compared, as are their implications for business management.
View Details
Keywords:
Judgments;
Courts and Trials;
Business or Company Management;
Standards;
Negotiation;
United States
Wheeler, Michael A., and Carlos Gonzalez. "Note on the Value of Life." Harvard Business School Background Note 902-152, June 2002.
- October 2013
- Case
FasterCures: Removing Barriers to Treatments
By: Richard G. Hamermesh and James Weber
In mid-2013, as FasterCures celebrated its 10th anniversary as a center of the Milken Institute, Executive Director Margaret Anderson thought about what the organization should do to ensure it had even more impact in its next 10 years. FasterCures was a non-profit... View Details
Keywords:
Health Care;
Health Care Industry;
Health Care Policy;
Health Services;
Healthcare;
Healthcare Reform;
Healthcare Ventures;
Nonprofit;
Non-profit Management;
Not-for-profit;
Incubator;
Accelerator;
Venture Philanthropy;
Medical Services;
Medical Solutions;
Medical Research;
Medical Treatment;
Clinical Trials;
Drug Reimbursement;
Early Stage;
Early Stage Research Funding;
Early Stage Funding;
Milken Institute;
Michael Milken;
David Baltimore;
Partnering For Cures;
National Institutes Of Health;
Cancer Care In The U.S.;
Cancer Care Services;
Policy-making;
Health Care and Treatment;
Health;
Health Testing and Trials;
Entrepreneurship;
Social Entrepreneurship;
Nonprofit Organizations;
Policy;
Health Industry;
United States;
District of Columbia
Hamermesh, Richard G., and James Weber. "FasterCures: Removing Barriers to Treatments." Harvard Business School Case 814-003, October 2013.
- 08 Aug 2017
- First Look
First Look at Research and Ideas, August 8, 2017
trials at Boston Children’s Hospital. As the founders prepare to bring their new medical device to market, they struggle with two key decisions: Should Luminopia create its own salesforce to sell its product or should it outsource? View Details
Keywords:
Sean Silverthorne